Abstract
The preparation of sterile parenteral products requires careful control of all ingredients, materials, and processes to ensure the final product has the identity and strength, and meets the quality and purity characteristics that it purports to possess. Contamination affecting these critical properties of parenteral products can occur in many ways and from many sources. The use of closures supplied by manufacturers in a ready-to-use state can be an effective method for reducing the risk of contamination and improving the quality of the drug product. This article will address contamination attributable to elastomeric container closure components and the regulatory requirements associated with container closure systems. Possible contaminants, including microorganisms, endotoxins, and chemicals, along with the methods by which these contaminants can enter the product will be reviewed. Such methods include inappropriate material selection, improper closure preparation processes, compromised container closure integrity, degradation of closures, and leaching of compounds from the closures.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Guidance for Industry: Container Closure Systems (CCS) for Packaging Human Drugs and Biologics. US Department of Health and Human Services Food and Drug Administration. 1999: May.
Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing—Current Good Manufacturing Practice. US Department of Health and Human Services Food and Drug Administration. 2004: Sept.
Guidance for Industry: Documentation for Sterilization Process Validation in Applications for Human and Veterinary Drug Products. U.S. Department of Health and Human Services Food and Drug Administration. 1994:May.
Code of Federal Regulations Title 21, Chapter 1—Part 211 Current Good Manufacturing Practice for Finished Pharmaceuticals. US Department of Health and Human Services Food and Drug Administration.
EudraLex The Rules Governing Medicinal Products in the European Union. Volume 4 EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use. Annex 1 Manufacture of Sterile Medicinal Products. European Commission. 2008: February.
Heinish KF. Dictionary of rubber. New York: Wiley; 1966.
Smith EJ, Nash RJ. Elastomeric closures for parenterals. In: Avis KE, Lieberman HA, Lachman L, editors. Pharmaceutical dosage forms: parenteral medications volume 1. 2nd ed. New York: Marcel Dekker; 1992. p. 445–507.
Morton M. Rubber technology. 2nd ed. Malabar: Robert E. Kreiger; 1981.
Lam P, Stern A. Visualization techniques for XXX affect the interaction between XXX stoppers, PDA. J Pharm Sci Tech. 2010;36:182–7.
Agalloco JP. The importance and future direction of sterilization processes, PDA sterilization technology today and tomorrow. San Juan, Puerto Rico. 2009; Nov.
Agalloco JP et al. Validation of moist heat sterilization processes: cycle design, development, qualification and ongoing control technical report no. 1. J Parenter Sci Technol. 2007;61:S-1.
Microbiology Sub-committee. Sterilization of Parenterals by Gamma Irradiation Technical Report No. 11. Journal of Parenteral Science and Technology. 1988:42,3S.
American National Standards Institute/Association for the Advancement of Medical Instrumentation/International Organization for Standardization 11137-1:2006/(R)2010—sterilization of health care products—radiation—part 1: requirements for the development, validation and routine control of a sterilization process for medical devices.
American National Standards Institute/Association for the Advancement of Medical Instrumentation/International Organization for Standardization 11137-2:2006—sterilization of health care products—radiation—part 2: establishing the sterilization dose.
American National Standards Institute/Association for the Advancement of Medical Instrumentation/International Organization for Standardization 11137-3:2006/(R)2010—sterilization of health care products—radiation—Part 3: guidance on dosimetric aspects.
Jacobs GP. Radiation sterilization of parenterals. Pharmaceutical Technology. 2007; May.
Woo L. Degradation mechanisms during and post gamma irradiation; invited lecture, Medical Design and Manufacturing West Conference, Anaheim, CA. Jan. 17, 1989.
Kiang P et al. Effect of gamma irradiation on elastomeric closures technical report No. 16. J Parenter Sci Technol. 1992;46:S2.
West Pharmaceutical Services. Closure storage and processing recommendations. Technical Support Bulletin 2001/001. 2005: July 22.
West Pharmaceutical Services. 4432/50 Gray functional study. Technical Support Report 2002/012. 2002.
Sterigenics. Material considerations—irradiation processing. http://www.sterigenics.com/services/medical_sterilization/contract_sterilization/material_consideration__irradiation_processing.pdf. Accessed 14 Apr 2010.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guest Editors: Lavinia Lewis, Jim Agalloco, Bill Lambert, Russell Madsen, and Mark Staples
Rights and permissions
About this article
Cite this article
Curry, W., Conway, S., Goodfield, C. et al. Reducing the Risk of Contamination of Sterile Parenteral Products via Ready-to-Use Closure Components. AAPS PharmSciTech 11, 1572–1579 (2010). https://doi.org/10.1208/s12249-010-9531-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-010-9531-8